STRS OHIO - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
STRS OHIO ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$12,000
-96.4%
500
-94.1%
0.00%
-100.0%
Q1 2022$329,000
-55.0%
8,500
-32.0%
0.00%
-66.7%
Q4 2021$731,000
-30.7%
12,500
-29.8%
0.00%
-25.0%
Q3 2021$1,055,000
-31.7%
17,8000.0%0.00%
-33.3%
Q2 2021$1,544,000
+18.6%
17,800
+12.7%
0.01%
+20.0%
Q1 2021$1,302,000
+30.2%
15,800
+43.6%
0.01%
+25.0%
Q4 2020$1,000,000
+383.1%
11,000
+111.5%
0.00%
+300.0%
Q3 2020$207,000
+125.0%
5,200
+92.6%
0.00%
Q2 2020$92,000
-94.1%
2,700
-96.6%
0.00%
-100.0%
Q4 2019$1,565,000
-37.0%
80,000
-50.0%
0.01%
+40.0%
Q3 2019$2,484,000
+53.0%
160,000
+100.0%
0.01%
-28.6%
Q2 2019$1,624,000
+15.6%
80,0000.0%0.01%
+16.7%
Q1 2019$1,405,000
+36.9%
80,0000.0%0.01%
+20.0%
Q4 2018$1,026,000
-22.4%
80,000
-1.5%
0.01%
-16.7%
Q3 2018$1,322,000
+43.7%
81,2000.0%0.01%
+50.0%
Q2 2018$920,000
+751.9%
81,200
+631.5%
0.00%
Q1 2018$108,000
+61.2%
11,1000.0%0.00%
Q4 2017$67,000
+55.8%
11,1000.0%0.00%
Q3 2017$43,000
+22.9%
11,1000.0%0.00%
Q2 2017$35,00011,1000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$7,163,6162.64%
Redmile Group, LLC 13,124,427$27,823,7851.32%
Monaco Asset Management SAM 1,847,944$3,917,6411.16%
Casdin Capital, LLC 2,050,000$4,346,0000.48%
TANG CAPITAL MANAGEMENT LLC 700,000$1,484,0000.21%
GCM Grosvenor Holdings, LLC 495,916$1,051,3420.21%
Nebula Research & Development LLC 163,617$346,8680.18%
Bellevue Group AG 4,851,579$10,285,3470.17%
Bruce & Co., Inc. 200,000$424,0000.14%
XTX Topco Ltd 192,920$408,9900.07%
View complete list of FATE THERAPEUTICS INC shareholders